Breaking News
Investing Pro 0
Last Call for Cyber Monday! Save Now on Claim 60% OFF

2 ETFs For Contrarian Investors Ready To Buy Chinese Stocks

By Investing.com (Tezcan Gecgil/Investing.com )ETFsAug 04, 2021 09:13
uk.investing.com/analysis/2-etfs-for-contrarian-investors-ready-to-buy-chinese-stocks-200490827
2 ETFs For Contrarian Investors Ready To Buy Chinese Stocks
By Investing.com (Tezcan Gecgil/Investing.com )   |  Aug 04, 2021 09:13
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
BYDDY
-1.40%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MPNGY
-2.16%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
DIDIY
-2.02%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2269
0.00%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
300760
-0.27%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
NIO
-1.65%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Recent headlines from China highlight that authorities there are cracking down on ‘platform businesses’ amid antitrust violations. The businesses that have felt the heavy hand of regulation include big tech names and online education providers, whose operations have grown significantly during the pandemic.

According to Time, “The People’s Daily, the mouthpiece of the Communist Party, warned… that fighting alleged monopolies was now a top priority.” The government also cancelled the initial public offering (IPO) of financial technology (fintech) giant Ant, an affiliate of Alibaba (NYSE:BABA)—a stock we recently covered here. The State Administration for Market Regulation (SAMR) has fined over a dozen tech giants for violation of anti-monopoly laws.

As a result, the share prices of a large number of widely-followed Chinese stocks have given up their prior gains, especially in the early months of the pandemic. On a side note, Cathie Wood’s Ark Invest has also been abandoning Chinese tech names.

YTD, here’s how several of the big Chinese technology stocks have fared:

  • Alibaba: down 14.2% YTD;
  • Baidu (NASDAQ:BIDU: down 22.9% YTD;
  • Didi Global (NYSE:DIDI): down 27.6% since going public in June:
  • New Oriental Education & Technology (NYSE:EDU): down 88.3% YTD;
  • Tencent (HK:0700) (OTC:TCEHY): down 14.7% YTD.

Both the Shenzhen Composite index and the Shanghai Composite, are also down about 5% year-to-date (YTD). In other words, they have underperformed US benchmarks so far this year.

Despite the current headwinds and question marks, long-term investors in Chinese stocks realize that they are buying into the growth prospects of the world’s second largest economy after the US. Recent metrics for the first half of 2021 highlight, “the economy grew by 12.7 percent, amid a low base effect from last year's coronavirus-triggered slump.” Further data on economic activity shows that the Chinese economy is on the path to recovery from the effects of the pandemic.

Thus, many investors might want to invest in Chinese shares due to their lower valuations. On the other hand, others could decide to stay put until there is more clarity on what might be the next move by regulators in the country. Therefore, today we’ll introduce two exchange-traded funds (ETFs) for those who want to take a contrarian view and buy China-based companies.

1. Global X MSCI China Consumer Discretionary ETF

  • Current price: $30.15
  • 52-week range: $24.34 - $43.90
  • Dividend yield: 0.07%
  • Expense ratio: 0.65% per year

Our first fund, the Global X MSCI China Consumer Disc ETF (NYSE:CHIQ), invests in large and mid-capitalization (cap) consumer discretionary firms with products and services that consumers might want, but do not necessarily need, to purchase. As China’s middle class grows, such business are likely to benefit from increased spending levels.

CHIQ Weekly
CHIQ Weekly

CHIQ, which has 83 holdings, provides investment results that corresponds to the MSCI China Consumer Discretionary 10/50 Index. The fund started trading November 2009.

In terms of sectors, we see internet and direct marketing retail (32%), followed by automobile manufacturers (22%) and education services (12%). The top 10 names make up about 54% of net assets of 758 million.

Leading holdings include Alibaba, e-commerce groups JD.com (NASDAQ:JD) and Pinduoduo (NASDAQ:PDD), food delivery platform Meituan (OTC:MPNGY), and car manufacturers Nio (NYSE:NIO) and Byd (OTC:BYDDY).

Although CHIQ returned over 27% in the past 52 weeks, it is down almost 15% YTD. Long-term investors bullish on consumer-themed Chinese businesses could consider researching the fund further. However, it is important to remember that Chinese policy decisions could mean more choppiness for many of the names in the ETF.

2. KraneShares MSCI All China Health Care Index ETF

  • Current price: $41.17

  • 52-week range: $32.40 - $47.69

  • Expense ratio: 0.65% per year

A recent report by McKinsey calls China “the most exciting healthcare story in the world right now.” The country spends 5.35% of its gross domestic product (GDP) on healthcare. By comparison, that number is 16.89% for the US, 11.43% for Germany, 10.95% for Japan, 10.00% for the UK, 5.56% for Romania, and 5.32% for Russia.

Our second fund, the KraneShares MSCI All China Health Care Index ETF (NYSE:KURE), gives exposure to the Chinese health care sector. Firms focus on pharmaceuticals, biotechnology, medical research, healthcare equipment, and supplies.

KURE Weekly
KURE Weekly

KURE, which has 116 holdings, measures the performance of MSCI China All Shares Health Care 10/40 Index. The fund started trading in January 2018. The top 10 names make up about 42% of net assets of 239 million.

Among the leading stocks in the roster are the provider of biologics services WuXi Biologics (HK:2269), Shenzhen Mindray Bio-Medical Electronics (SZ:300760), which manufactures medical imaging and diagnostic equipment, WuXi AppTec (SS:603259) which focuses on pharmaceutical research and development (R&D) and manufacturing, and Aier Eye Hospital Group (SZ:300015).

The fund returned 11% up in the past year and 2% YTD. If you believe China’s growing middle class, as well as its ageing population, could fuel the holdings of KURE in coming quarters, then you might consider buying the dips in the fund.

2 ETFs For Contrarian Investors Ready To Buy Chinese Stocks
 

Related Articles

Gary Tanashian
Gold Stocks: Is the Time Really Now? By Gary Tanashian - Nov 16, 2023 2

Gold stocks are not yet unique within the wider macro, but that does not preclude a move to 40 by GDX (NYSE:GDX). Interestingly, however, on the day this was written (pre-market,...

2 ETFs For Contrarian Investors Ready To Buy Chinese Stocks

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (1)
som sithy
som sithy Aug 04, 2021 9:17
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Muluhkoh Jovice
Muluhkoh Jovice Aug 04, 2021 9:17
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hello
Muluhkoh Jovice
Muluhkoh Jovice Aug 04, 2021 9:17
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hello
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email